Dapsone Tablet
Product Images NDC 69367-378

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone (NDC 69367-378). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dapsone 01)

Chemical structure of dapsone, displaying two benzene rings connected by a sulfone (SO2) group, with each benzene ring bearing an amino (NH2) group.*

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Label for Dapsone Tablets USP 25 mg oral tablets by Westminster Pharmaceuticals. The label indicates a package of 30 tablets with storage instructions and a caution about federal prescription laws. The label includes the NDC 69367-378-30 and bar code.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Label for Dapsone 100 mg tablets, USP, oral dosage form by Westminster Pharmaceuticals, LLC. The carton shows the NDC 69367-379-30 and contains 30 tablets. The label includes storage instructions, caution about prescription dispensing, and distributor information in Nashville, TN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.